<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03220464</url>
  </required_header>
  <id_info>
    <org_study_id>1704-157-849</org_study_id>
    <nct_id>NCT03220464</nct_id>
  </id_info>
  <brief_title>Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT</brief_title>
  <official_title>Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate ultra low dose chest computed tomography (ULDCT) for
      early diagnosis of active tuberculosis in cohort of close contacts of active pulmonary
      tuberculosis for 1 year follow up
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early diagnosis of active tuberculosis in close contacts have not yet been established.
      To evaluate the early detection of active pulmonary tuberculosis using ULDCT, the
      investigators will establish the observational cohort of close contacts living in the same
      space with active pulmonary tuberculosis. Participants will visit our center at enrollment,
      after 3 months, and 12 months and will be received ULDCT, chest X-ray and Interferon-gamma
      assays at each visit. One chest radiologist will interpret findings of ULDCT and chest X-ray.

      Patients diagnosed with active tuberculosis will be excluded from the study and treated based
      on World Health Organization guidelines.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of active pulmonary tuberculosis</measure>
    <time_frame>For a year</time_frame>
    <description>Active pulmonary tuberculosis defined by WHO guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of active pulmonary tuberculosis at enrollment</measure>
    <time_frame>Baseline</time_frame>
    <description>Active pulmonary tuberculosis defined by WHO guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of latent tuberculosis at enrollment</measure>
    <time_frame>Baseline</time_frame>
    <description>Latent tuberculosis defined by guidelines on the management of latent tuberculosis infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of ultra low dose chest CT findings in latent tuberculosis patients</measure>
    <time_frame>Baseline, 3-month follow-up, and 12-month follow-up</time_frame>
    <description>Serial comparison analysis of CT findings in latent tuberculosis patients who diagnosed latent tuberculosis based on IFN-gamma assay</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Tuberculosis, Pulmonary</condition>
  <condition>Latent Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Close contacts of active pulmonary tuberculosis patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One arm study of conducting ULDCT, chest x-ray, and IGRA</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultra low dose chest computed tomography (ULDCT)</intervention_name>
    <description>Participants in the study will receive ULDCT at enrollment, after 3-month visit, and after 12-month visit.</description>
    <arm_group_label>Close contacts of active pulmonary tuberculosis patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Chest X-ray</intervention_name>
    <description>Participants in the study will receive chest x-ray at enrollment, after 3-month visit, and after 12-month visit.</description>
    <arm_group_label>Close contacts of active pulmonary tuberculosis patients</arm_group_label>
    <other_name>Chest radiograph</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Interferon-gamma Release Assay (IGRA)</intervention_name>
    <description>Participants in the study will receive IGRA test at enrollment, after 3-month visit, and after 12-month visit. About 11mL of blood will be drawn from the participants for test of T-SPOTÂ®.TB test and QuantiFERON test.</description>
    <arm_group_label>Close contacts of active pulmonary tuberculosis patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Close contacts of active pulmonary tuberculosis

          -  Family members of active TB patient who has lived together for more than one month, or
             work colleagues of active TB patient who has been working in the same office for more
             than 8 months

          -  Participants who received explanation of the research plan, understands and writes
             agreement.

        Exclusion Criteria:

          -  Vulnerable subjects with mental retardation or severe mental illness

          -  Patients who could not receive chest CT

          -  Pregnancy

          -  Close contacts who diagnosed active pulmonary tuberculosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae-Joon Yim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae-Joon Yim, MD, PhD</last_name>
    <phone>82-2-2072-2059</phone>
    <email>yimjj@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Joon Yim, MD, PhD</last_name>
      <phone>+82-2-2072-2059</phone>
      <email>yimjj@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Jin Hwa Song, MD</last_name>
      <phone>+82-2-2072-2217</phone>
      <email>songjh86@hanmail.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.who.int/tb/publications/2010/9789241547833/en/</url>
    <description>Treatment of tuberculosis: guidelines</description>
  </link>
  <link>
    <url>http://www.who.int/tb/publications/latent-tuberculosis-infection/en/</url>
    <description>Guidelines on the management of latent tuberculosis infection</description>
  </link>
  <reference>
    <citation>World Health Organization, and Stop TB Initiative (World Health Organization). Treatment of tuberculosis: guidelines. World Health Organization, 2010.</citation>
  </reference>
  <reference>
    <citation>World Health Organization (World Health Organization). Guidelines on the management of latent tuberculosis infection. World Health Organization, 2015.</citation>
  </reference>
  <results_reference>
    <citation>Lee SW, Jang YS, Park CM, Kang HY, Koh WJ, Yim JJ, Jeon K. The role of chest CT scanning in TB outbreak investigation. Chest. 2010 May;137(5):1057-64. doi: 10.1378/chest.09-1513. Epub 2009 Oct 31.</citation>
    <PMID>19880906</PMID>
  </results_reference>
  <results_reference>
    <citation>Piccazzo R, Paparo F, Garlaschi G. Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review. J Rheumatol Suppl. 2014 May;91:32-40. doi: 10.3899/jrheum.140100. Review.</citation>
    <PMID>24788998</PMID>
  </results_reference>
  <results_reference>
    <citation>Lew WJ, Jung YJ, Song JW, Jang YM, Kim HJ, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS. Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak. Int J Tuberc Lung Dis. 2009 May;13(5):633-9.</citation>
    <PMID>19383198</PMID>
  </results_reference>
  <results_reference>
    <citation>Fujikawa A, Fujii T, Mimura S, Takahashi R, Sakai M, Suzuki S, Kyoto Y, Uwabe Y, Maeda S, Mori T. Tuberculosis contact investigation using interferon-gamma release assay with chest x-ray and computed tomography. PLoS One. 2014 Jan 14;9(1):e85612. doi: 10.1371/journal.pone.0085612. eCollection 2014.</citation>
    <PMID>24454900</PMID>
  </results_reference>
  <results_reference>
    <citation>Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med. 2014 Nov 1;190(9):1044-52. doi: 10.1164/rccm.201406-1159OC.</citation>
    <PMID>25265362</PMID>
  </results_reference>
  <results_reference>
    <citation>Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013 Jan;41(1):140-56. doi: 10.1183/09031936.00070812. Epub 2012 Aug 30. Review. Erratum in: Eur Respir J. 2015 Aug;46(2):578.</citation>
    <PMID>22936710</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2017</study_first_submitted>
  <study_first_submitted_qc>July 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jae-Joon Yim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Interferon-gamma</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

